Cart (0 Items)
Your cart is currently empty.
View Products-
-
-
Lifastuzumab Biosimilar – Anti-SLC34A2 mAb – Research Grade
| Size | 100ug, 1MG |
|---|---|
| Isotype | IgG1, kappa |
| Brand | ProteoGenix |
| Product type | Primary Antibodies |
| Clonality | Monoclonal Antibody |
| Expression system | Mammalian cells |
| Applications | Elisa, WB |
| Product name | Lifastuzumab Biosimilar - Anti-SLC34A2 mAb - Research Grade |
|---|---|
| Source | CAS 1401812-88-1 |
| Species | Humanized |
| Expression system | Mammalian cells |
| Purity | >85% |
| Buffer | PBS buffer PH7.5 |
| Delivery condition | Blue ice (+4°C) |
| Delivery Time | 3-5 days if in stock; 3-5 weeks if production needed |
| Storage condition | store at -80°C |
| Brand | ProteoGenix |
| Aliases /Synonyms | Lifastuzumab,DNIB0600A (conjugate),MNIB2126A (non conjugate),SLC34A2,anti-SLC34A2 |
| Reference | PX-TA1334 |
| Note | For research use only. Not suitable for clinical or therapeutic use. |
| Isotype | IgG1-kappa |
| Clonality | Monoclonal Antibody |
Description of Lifastuzumab Biosimilar - Anti-SLC34A2 mAb - Research Grade
General information on Anti-SLC34A2[Homo sapiens] (Lifastuzumab) Monoclonal Antibody
Lifastuzumab is investigated for the treatment of Non-Small Cell Lung Cancer (NSCLC) and Platinum Resistant Ovarian Cancer.
SDS-PAGE for Lifastuzumab Biosimilar - Anti-SLC34A2 mAb
Lifastuzumab Biosimilar - Anti-SLC34A2 mAb, on SDS-PAGE under reducing and non-reducing condition. The gel was stained overnight with Coomassie Blue. The purity of the antibody is greater than 95%.
Related products
Antigen
Sodium-dependent phosphate transport protein 2B(SLC34A2)
PX-P4875 210€Contact us
Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.
Reviews
There are no reviews yet.